Follow
Marvin Martens
Marvin Martens
PhD Candidate, Maastricht University
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research
DN Slenter, M Kutmon, K Hanspers, A Riutta, J Windsor, N Nunes, ...
Nucleic acids research 46 (D1), D661-D667, 2018
8552018
WikiPathways: connecting communities
M Martens, A Ammar, A Riutta, A Waagmeester, DN Slenter, K Hanspers, ...
Nucleic acids research 49 (D1), D613-D621, 2021
5562021
Adverse outcome pathways: opportunities, limitations and open questions
M Leist, A Ghallab, R Graepel, R Marchan, R Hassan, SH Bennekou, ...
Archives of Toxicology 91, 3477-3505, 2017
3202017
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
M Ostaszewski, A Niarakis, A Mazein, I Kuperstein, R Phair, ...
Molecular systems biology 17 (10), e10387, 2021
762021
Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
C Anfray, F Mainini, E Digifico, A Maeda, M Sironi, M Erreni, A Anselmo, ...
Journal for ImmunoTherapy of Cancer 9 (9), 2021
482021
Introducing WikiPathways as a data-source to support adverse outcome pathways for regulatory risk assessment of chemicals and nanomaterials
M Martens, T Verbruggen, P Nymark, R Grafström, LD Burgoon, H Aladjov, ...
Frontiers in genetics 9, 661, 2018
372018
Metabolism and toxicity of fluorine compounds
JL Kyzer, M Martens
Chemical Research in Toxicology 34 (3), 678-680, 2021
292021
Genome-wide strategies identify downstream target genes of chick connective tissue-associated transcription factors
M Orgeur, M Martens, G Leonte, S Nassari, MA Bonnin, ST Börno, ...
Development 145 (7), dev161208, 2018
182018
Towards a qAOP framework for predictive toxicology-Linking data to decisions
A Paini, I Campia, MTD Cronin, D Asturiol, L Ceriani, TE Exner, W Gao, ...
Computational Toxicology 21, 100195, 2022
172022
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop
LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ...
Altex 39 (2), 322–335, 2022
162022
A strategy towards the generation of testable adverse outcome pathways for nanomaterials
S Murugadoss, IV Vrcek, B Pem, K Jagiello, B Judzinska, A Sosnowska, ...
ALTEX-Alternatives to animal experimentation 38 (4), 580-594, 2021
162021
Providing adverse outcome pathways from the AOP-wiki in a semantic web format to increase usability and accessibility of the content
M Martens, CT Evelo, EL Willighagen
Applied in Vitro Toxicology 8 (1), 2-13, 2022
132022
Ten simple rules for creating reusable pathway models for computational analysis and visualization
K Hanspers, M Kutmon, SL Coort, D Digles, LJ Dupuis, F Ehrhart, F Hu, ...
PLoS computational biology 17 (8), e1009226, 2021
132021
A dual transcript-discovery approach to improve the delimitation of gene features from RNA-seq data in the chicken model
M Orgeur, M Martens, ST Börno, B Timmermann, D Duprez, S Stricker
Biology Open 7 (1), bio028498, 2018
112018
The AOP-DB RDF: Applying FAIR principles to the semantic integration of AOP data using the research description framework
HM Mortensen, M Martens, J Senn, T Levey, CT Evelo, EL Willighagen, ...
Frontiers in Toxicology 4, 803983, 2022
62022
A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma
M Martens, F Kreidl, F Ehrhart, D Jean, M Mei, HM Mortensen, A Nash, ...
Frontiers in oncology 12, 849640, 2022
52022
WikiPathways 2024: next generation pathway database
A Agrawal, H Balcı, K Hanspers, SL Coort, M Martens, DN Slenter, ...
Nucleic acids research 52 (D1), D679-D689, 2024
22024
ELIXIR and Toxicology: a community in development
M Martens, R Stierum, EL Schymanski, CT Evelo, R Aalizadeh, H Aladjov, ...
F1000Research 10 (1129), 1129, 2021
22021
Why adverse outcome pathways need to be FAIR
C Wittwehr, LA Clerbaux, S Edwards, M Angrish, H Mortensen, A Carusi, ...
ALTEX-Alternatives to animal experimentation 41 (1), 50-56, 2024
12024
Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals
S Murugadoss, IV Vrček, A Schaffert, M Paparella, B Pem, A Sosnowska, ...
12023
The system can't perform the operation now. Try again later.
Articles 1–20